Accessibility Menu
Nova Eye Medical logo

Nova Eye Medical

(ASX) EYE

Current PriceA$0.12
Market CapA$34.18M
Since IPO (1992)-51%
5 Year-61%
1 Year+0%
1 Month-8%

Nova Eye Medical Financials at a Glance

Market Cap

A$34.18M

Revenue (TTM)

A$59.16M

Net Income (TTM)

-A$15.59M

EPS (TTM)

-A$0.02

P/E Ratio

-4.82

Dividend

A$0.00

Beta (Volatility)

0.25 (Low)

Price

A$0.12

Volume

174,400

Open

A$0.11

Previous Close

A$0.12

Daily Range

A$0.11 - A$0.12

52-Week Range

A$0.10 - A$0.21

Estimated Earnings Date

Aug 26, 2026

EYE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nova Eye Medical

Industry

Healthcare Equipment and Supplies

CEO

Thomas Spurling

Headquarters

Kent Town, SA 5067, AU

EYE Financials

Key Financial Metrics (TTM)

Gross Margin

67%

Operating Margin

-16%

Net Income Margin

-21%

Return on Equity

-42%

Return on Capital

-29%

Return on Assets

-30%

Earnings Yield

-20.75%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$34.18M

Shares Outstanding

284.87M

Volume

174.40K

Avg. Volume

266.08K

Financials (TTM)

Gross Profit

A$20.07M

Operating Income

-A$11.25M

EBITDA

-A$8.99M

Operating Cash Flow

-A$6.15M

Capital Expenditure

-A$426.00K

Free Cash Flow

-A$6.58M

Cash & ST Invst.

A$5.06M

Total Debt

A$3.02M

Nova Eye Medical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$16.71M

+64.8%

Gross Profit

A$11.72M

+786.3%

Gross Margin

70.11%

N/A

Market Cap

A$34.18M

N/A

Market Cap/Employee

A$113.57K

N/A

Employees

301

N/A

Net Income

-A$3.37M

+40.2%

EBITDA

-A$2.36M

+43.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$2.62M

+0.4%

Total Debt

A$4.94M

+306.6%

Accounts Receivable

A$4.10M

+85.8%

Inventory

A$3.50M

-15.3%

Long Term Debt

A$4.29M

+668.2%

Short Term Debt

A$646.00K

-50.8%

Return on Assets

-29.70%

N/A

Return on Invested Capital

-29.00%

N/A

Free Cash Flow

-A$2.41M

+46.1%

Operating Cash Flow

-A$2.28M

+44.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IIQ.AXINOVIQ Ltd
A$0.32+0.00%
HMD.AXHeraMED Limited
A$0.04+2.70%
NXS.AXNext Science Limited
A$0.15+0.00%
BDX.AXBCAL Diagnostics Limited
A$0.07+2.94%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$14.98+0.02%
INTCIntel
$124.57+0.07%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$77.52+0.02%

Questions About EYE

What is the current price of Nova Eye Medical?

Nova Eye Medical is trading at A$0.12 per share.

What is the 52-week range for Nova Eye Medical?

Over the past 52 weeks, Nova Eye Medical has traded between A$0.10 and A$0.21.

How much debt does Nova Eye Medical have?

As of the most recent reporting period, Nova Eye Medical reported total debt of A$3.02M.

How much cash does Nova Eye Medical have on hand?

Nova Eye Medical reported A$5.06M in cash and cash equivalents in its most recent financial results.

What is Nova Eye Medical’s dividend yield?

Nova Eye Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.